NCT02885376View on ClinicalTrials.gov

Study of Dentoxol® Mouthrinse for Oral Mucositis

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

August 31, 2018

Conditions
Oral Mucositis
Interventions
DEVICE

Dentoxol

Mouthrinse

DEVICE

Placebo

Mouthrinse

Trial Locations (3)

Unknown

Clinica IRAM, Santiago

Fundación Arturo López Pérez, Santiago

Instituto Nacional del Cáncer, Santiago

All Listed Sponsors
lead

Ingalfarma SpA

INDUSTRY

NCT02885376 - Study of Dentoxol® Mouthrinse for Oral Mucositis | Biotech Hunter | Biotech Hunter